Fusion event
HBV-chr2 integration
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Integrated sequence
ACGACCGACCTTGAGGCATACTTCAAAGACTGTTTGTTTAAAGACTGGGAGGAGTTGGGGGAGGAGATTAGGTTAAAGGTCTTTGTACTAGGAGGCTGTA| |GGCATAAATTGGTCTGCGCACCAGCACCATGCAACTTTTTCACCTCTGCCTAATCATCTCTTGTTCATGTCCTACTGTTCAAGCCTCCAAGCTGTGCCTT
End
217431610/216566887 (Hg38)
Nearest miRNA
hsa-mir-10b/Upstream/2808728; hsa-mir-1244-1/Downstream/1333626;
Upstream sequence
gcgcctgtagtcccagctactcgggaggctgaggcaggaggatggcgtgaatccgggaggcggagtttgcagtgagctgagatcgcgccactgcactcca
Downstream sequence
gcctgggcgacagagcgagactccgtctcaaaaacaaaacaaaacaaaacaaaacagaaaacaaaaaagtctgcagacgcaacaaacaacaggattagac
Yang, L., et al. Molecular Characterization of HBV DNA Integration in Patients with Hepatitis and Hepatocellular Carcinoma. J Cancer ,2018,9(18): 3225-3235.